Dr. Lucia Gemma Delogu
Lucia Gemma Delogu, Ph.D., is the head of the ImmuneNano-Lab at the Department of Biomedical Sciences of the University of Padua (UNIPD Padua, Italy) www.delogulab.eu. After acquiring her experience in Immunology and Material Science at the University of Southern California (Los Angeles, USA) and at Sanford-Burnham Institute (San Diego, USA), she served as Assistant Professor at the University of Sassari (Italy) and as Visiting Professor at the Technische Universität Dresden (TUD; Dresden, Germany).
Dr. Delogu has been the Scientific Coordinator of two interdisciplinary EU projects, under HORIZON2020, including a RISE project on nanomedicine and immune interactions of nanomaterials, involving more than 10 leading Institutions and high-profile international scientists on nanotechnology and nanomedicine. In this field, she has received several awards, including the “Marie S. Curie Individual Fellow” at TUD under HORIZON2020 from the European Commission, the “200 Young Best Talents of Italy 2011” from the Italian Ministry of Youth, and “Bedside to Bench & Back Award” from the National Institutes of Health, USA. Since 2020, Dr. Delogu is in charge of the Italian chapter and a member of the road map working group of the Advanced Material Global Pandemic & Future Preparedness Taskforce (AMPT) www.amptnetwork.com/. She introduced the “NanoImmunity-by-design” concept, for the design of nanomaterials based not solely on their physicochemical characteristics but also on their immunomodulatory characteristics.
She pioneered the use of systems immunology approach by high-dimensional single-cell strategies in the context of nanomaterial applications. Her research focuses on the biological interactions of nanomaterials and nanoparticles, with a particular focus on their immunomodulation properties, biomedical applications and toxicological profile.